Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Breast 1

Conditions

Motor Activity 1Leukemia, Myeloid, Acute 1Fatigue 1Breast Cancer With Chronic Lymphedema 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Waiting Lists × Clear all
NCT01706081 2019-08-29

Acupuncture for Chronic Lymphedema

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
82 enrolled 10 charts
Breast

Breast Cancer With Chronic Lymphedema

NCT00764231 2012-02-08

A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)

Toronto Rehabilitation Institute

Phase 2 Completed
40 enrolled
Other hematologic neoplasm

Fatigue, Motor Activity, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡